A RAPIDLY PROGRESSIVE AND RARE ILLNESS: AUTOANTIBODIES AGAINST MELANOMA DIFFERENTIATION-ASSOCIATED PROTEIN 5 (ANTI-MDA5): AMYOPATHIC DERMATOMYOSITIS WITH PROGRESSIVE INTERSTITIAL LUNG DISEASE THAT DEVELOPED AFTER COVID-19 VACCINE

Detalles Bibliográficos
Autores principales: CARRASCO, LEONEL, ARTHUR, ASHLIE, GAITAN RUEDA, JUAN, CASE, CHAD
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American College of Chest Physicians. Published by Elsevier Inc. 2021
Materias:
Critical Care
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8503139/
http://dx.doi.org/10.1016/j.chest.2021.07.646
_version_ 1784581047510368256
author CARRASCO, LEONEL
ARTHUR, ASHLIE
GAITAN RUEDA, JUAN
CASE, CHAD
author_facet CARRASCO, LEONEL
ARTHUR, ASHLIE
GAITAN RUEDA, JUAN
CASE, CHAD
author_sort CARRASCO, LEONEL
collection PubMed
description
format Online
Article
Text
id pubmed-8503139
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher American College of Chest Physicians. Published by Elsevier Inc.
record_format MEDLINE/PubMed
spelling pubmed-85031392021-10-12 A RAPIDLY PROGRESSIVE AND RARE ILLNESS: AUTOANTIBODIES AGAINST MELANOMA DIFFERENTIATION-ASSOCIATED PROTEIN 5 (ANTI-MDA5): AMYOPATHIC DERMATOMYOSITIS WITH PROGRESSIVE INTERSTITIAL LUNG DISEASE THAT DEVELOPED AFTER COVID-19 VACCINE CARRASCO, LEONEL ARTHUR, ASHLIE GAITAN RUEDA, JUAN CASE, CHAD Chest Critical Care American College of Chest Physicians. Published by Elsevier Inc. 2021-10 2021-10-11 /pmc/articles/PMC8503139/ http://dx.doi.org/10.1016/j.chest.2021.07.646 Text en Copyright © 2021 American College of Chest Physicians. Published by Elsevier Inc. All rights reserved. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active.
spellingShingle Critical Care
CARRASCO, LEONEL
ARTHUR, ASHLIE
GAITAN RUEDA, JUAN
CASE, CHAD
A RAPIDLY PROGRESSIVE AND RARE ILLNESS: AUTOANTIBODIES AGAINST MELANOMA DIFFERENTIATION-ASSOCIATED PROTEIN 5 (ANTI-MDA5): AMYOPATHIC DERMATOMYOSITIS WITH PROGRESSIVE INTERSTITIAL LUNG DISEASE THAT DEVELOPED AFTER COVID-19 VACCINE
title A RAPIDLY PROGRESSIVE AND RARE ILLNESS: AUTOANTIBODIES AGAINST MELANOMA DIFFERENTIATION-ASSOCIATED PROTEIN 5 (ANTI-MDA5): AMYOPATHIC DERMATOMYOSITIS WITH PROGRESSIVE INTERSTITIAL LUNG DISEASE THAT DEVELOPED AFTER COVID-19 VACCINE
title_full A RAPIDLY PROGRESSIVE AND RARE ILLNESS: AUTOANTIBODIES AGAINST MELANOMA DIFFERENTIATION-ASSOCIATED PROTEIN 5 (ANTI-MDA5): AMYOPATHIC DERMATOMYOSITIS WITH PROGRESSIVE INTERSTITIAL LUNG DISEASE THAT DEVELOPED AFTER COVID-19 VACCINE
title_fullStr A RAPIDLY PROGRESSIVE AND RARE ILLNESS: AUTOANTIBODIES AGAINST MELANOMA DIFFERENTIATION-ASSOCIATED PROTEIN 5 (ANTI-MDA5): AMYOPATHIC DERMATOMYOSITIS WITH PROGRESSIVE INTERSTITIAL LUNG DISEASE THAT DEVELOPED AFTER COVID-19 VACCINE
title_full_unstemmed A RAPIDLY PROGRESSIVE AND RARE ILLNESS: AUTOANTIBODIES AGAINST MELANOMA DIFFERENTIATION-ASSOCIATED PROTEIN 5 (ANTI-MDA5): AMYOPATHIC DERMATOMYOSITIS WITH PROGRESSIVE INTERSTITIAL LUNG DISEASE THAT DEVELOPED AFTER COVID-19 VACCINE
title_short A RAPIDLY PROGRESSIVE AND RARE ILLNESS: AUTOANTIBODIES AGAINST MELANOMA DIFFERENTIATION-ASSOCIATED PROTEIN 5 (ANTI-MDA5): AMYOPATHIC DERMATOMYOSITIS WITH PROGRESSIVE INTERSTITIAL LUNG DISEASE THAT DEVELOPED AFTER COVID-19 VACCINE
title_sort rapidly progressive and rare illness: autoantibodies against melanoma differentiation-associated protein 5 (anti-mda5): amyopathic dermatomyositis with progressive interstitial lung disease that developed after covid-19 vaccine
topic Critical Care
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8503139/
http://dx.doi.org/10.1016/j.chest.2021.07.646
work_keys_str_mv AT carrascoleonel arapidlyprogressiveandrareillnessautoantibodiesagainstmelanomadifferentiationassociatedprotein5antimda5amyopathicdermatomyositiswithprogressiveinterstitiallungdiseasethatdevelopedaftercovid19vaccine
AT arthurashlie arapidlyprogressiveandrareillnessautoantibodiesagainstmelanomadifferentiationassociatedprotein5antimda5amyopathicdermatomyositiswithprogressiveinterstitiallungdiseasethatdevelopedaftercovid19vaccine
AT gaitanruedajuan arapidlyprogressiveandrareillnessautoantibodiesagainstmelanomadifferentiationassociatedprotein5antimda5amyopathicdermatomyositiswithprogressiveinterstitiallungdiseasethatdevelopedaftercovid19vaccine
AT casechad arapidlyprogressiveandrareillnessautoantibodiesagainstmelanomadifferentiationassociatedprotein5antimda5amyopathicdermatomyositiswithprogressiveinterstitiallungdiseasethatdevelopedaftercovid19vaccine
AT carrascoleonel rapidlyprogressiveandrareillnessautoantibodiesagainstmelanomadifferentiationassociatedprotein5antimda5amyopathicdermatomyositiswithprogressiveinterstitiallungdiseasethatdevelopedaftercovid19vaccine
AT arthurashlie rapidlyprogressiveandrareillnessautoantibodiesagainstmelanomadifferentiationassociatedprotein5antimda5amyopathicdermatomyositiswithprogressiveinterstitiallungdiseasethatdevelopedaftercovid19vaccine
AT gaitanruedajuan rapidlyprogressiveandrareillnessautoantibodiesagainstmelanomadifferentiationassociatedprotein5antimda5amyopathicdermatomyositiswithprogressiveinterstitiallungdiseasethatdevelopedaftercovid19vaccine
AT casechad rapidlyprogressiveandrareillnessautoantibodiesagainstmelanomadifferentiationassociatedprotein5antimda5amyopathicdermatomyositiswithprogressiveinterstitiallungdiseasethatdevelopedaftercovid19vaccine

Ejemplares similares